Biorepository and integrative genomics initiative: designing and implementing a preliminary platform for predictive, preventive and personalized medicine at a pediatric hospital in a historically disadvantaged community in the USA
Current healthcare is evolving to emphasize cost-effective care by leveraging results and outcomes of genomic and other advanced research efforts in clinical care and preventive health planning. Through a collaborative effort between the University of Tennessee Health Science Center (UTHSC) and Le Bonheur Children’s Hospital (LBCH), the Biorepository and Integrative Genomics (BIG) Initiative was established to set up a pediatric-based DNA biorepository that can serve as a foundation for successful development of delivery platforms for predictive, preventive, and personalized medical services in Memphis, Tennessee, a historically disadvantaged community in the USA. In this paper, we describe the steps that were followed to establish the biorepository. We focused on domains that are essential for implementation of a biorepository for genomic research as an initial goal and identified patient consent, DNA extraction, storage and dissemination, and governance as essential components. Specific needs in each of these domains were addressed by respective solutions developed by multidisciplinary teams under the guidance of a governance model that involved experts from multiple hospital arenas and community members. The end result was the successful launch of a large-scale DNA biorepository, with patient consent greater than 75% in the first year. Our experience highlights the importance of performing pre-design research, needs assessment, and designing an ethically vetted plan that is cost-effective, easy to implement, and inclusive of the community that is served. We believe this biorepository model, with appropriate tailoring according to organizational needs and available resources, can be adopted and successfully applied by other small- to mid-sized healthcare organizations.
KeywordsBiobank Integrative genomics initiative Predictive preventive personalized medicine Pediatrics Community
Compliance with ethical standards
The authors declare that they have no competing interests.
Consent for publication
The authors provide consent for publication.
All the patient investigations conformed to the principles outlined in the Declaration of Helsinki and have been performed with the permission (IRB Approval Number—15-03639-XP) released by the responsible Ethics Committee/Institutional Regulatory Board of the University of Tennessee Health Science Center. All the patients were informed about the purposes of the study and have signed their “consent of the patient.” This article does not contain any studies with animals performed by any of the authors.
- 3.Delavarga E. Memphis poverty fact sheet. 2017. http://www.memphis.edu/socialwork/research/2017povertyfactsheetwebversion.pdf.
- 4.Centers for Disease Control. Behavioral risk factor surveillance system 2016 system data and documentation. 2018. https://www.cdc.gov/brfss/annual_data/annual_2016.html.
- 17.National Human Research Institute. NHGRI implementation of the NIH Genomic Data Sharing (GDS) Policy. https://www.genome.gov/27562511#al-2.
- 18.U.S. Department of Health & Human Services. Federal policy for the protection of human subjects (‘Common Rule’). https://www.hhs.gov/ohrp/regulations-and-policy/regulations/common-rule/index.html.
- 21.Campbell LD, Astrin JJ, DeSouza Y, Giri J, Patel AA, Rawley-Payne M, et al. The 2018 revision of the ISBER best practices: summary of changes and the editorial Team's development process. Biopreserv Biobank. 16(1):3–6.21.Google Scholar
- 22.CFR Parts 50 and 56: Additional Safeguards for Children in Clinical Investigations of Food and Drug Administration-Regulated Products https://www.gpo.gov/fdsys/pkg/FR-2013-02-26/pdf/2013-04387.pdf.
- 23.Title 45: Public Welfare, Part 46, Protection of Human Subjects. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html.
- 24.45 CFR Part 160 and Subparts A and E: https://www.gpo.gov/fdsys/pkg/CFR-2007-title45-vol1/pdf/CFR-2007-title45-vol1.pdf.
- 25.45 CFR Part 160 and Subparts A and E Simplification: https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/administrative/combined/hipaa-simplification-201303.pdf.
- 26.45 CFR Part 160 and Subparts A and E for Professionals: https://www.hhs.gov/hipaa/for-professionals/privacy/index.html.
- 27.The Genetic Information Nondiscrimination Act of 2008, Information for Researchers and Health Care Professionals: https://www.genome.gov/pages/policyethics/geneticdiscrimination/ginainfodoc.pdf.
- 28.Final NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-094.html.
- 29.Federal Policy for the Protection of Human Subjects; Final Rule: https://www.gpo.gov/fdsys/pkg/FR-2017-01-19/html/2017-01058.htm.
- 30.Federal Policy for the Protection of Human Subjects; Rules and Regulations: https://www.gpo.gov/fdsys/pkg/FR-2018-01-22/pdf/2018-00997.pdf.
- 33.Redcap (Research Electronic Data Capture) https://www.project-redcap.org.
- 34.Evans RS, Lloyd JF, Pierce LA. Clinical use of an enterprise data warehouse. AMIA Ann Symp Proc. 2012;2012:189–98.Google Scholar
- 35.Northwestern Medicine Enterprise Data Warehouse (NMEDW): http://nucats.northwestern.edu/resources/data-science-and-informatics/nmedw/index.html.
- 36.VCU and VCU Health System, single Enterprise Data Warehouse (EDW) https://cctr.vcu.edu/informatics/edw/index.html.
- 37.NIH’s Certificates of Confidentiality Policy Enhances Confidentiality of Participants Enrolled in Clinical Research Studies: https://nexus.od.nih.gov/all/2017/09/07/nih-new-certificates-of-confidentiality-policy.
- 38.NIH Certificates of Confidentiality (CoC): https://humansubjects.nih.gov/coc/index.